Human CST abundance determines recovery from diverse forms of DNA damage and replication stress

Cell Cycle

Volumn 13, Issue 22, 2014, Pages 3488-3498

  Wang, Feng ^a,b   Stewart, Jason ^a,c   Price, Carolyn M ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

CTC1; Dna repair; Dna replication; Replication origin; STN1; Telomere; TEN1

Indexed keywords

APHIDICOLIN; CAMPTOTHECIN; CST PROTEIN; HYDROXYUREA; PARATHION; TELOMERE BINDING PROTEIN; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; CLSTN1 PROTEIN, HUMAN; DNA DIRECTED DNA POLYMERASE BETA; STN1 PROTEIN, HUMAN; TELOMERASE; TEN1 PROTEIN, HUMAN;

ANAPHASE; ARTICLE; CELL CYCLE S PHASE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; DNA DAMAGE CHECKPOINT; HUMAN; HUMAN CELL; MICRONUCLEUS; PROTEIN EXPRESSION; STOICHIOMETRY; ANIMAL; DNA REPLICATION; DRUG EFFECTS; GENETICS; HELA CELL LINE; METABOLISM; TELOMERE;

MAMMALIA;

ANIMALS; CALCIUM-BINDING PROTEINS; DNA DAMAGE; DNA POLYMERASE I; DNA REPLICATION; HELA CELLS; HUMANS; HYDROXYUREA; TELOMERASE; TELOMERE; TELOMERE-BINDING PROTEINS;

EID: 84919922695     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.964100     Document Type: Article

References (66)

1. Zeman MK, Cimprich KA. Causes and consequences of replication stress. Nat Cell Biol 2014; 16:2-9; PMID: 24366029; http://dx.doi.org/10.1038/ncb2897
2. Branzei D, Foiani M. Maintaining genome stability at the replication fork. Nat Rev Mol Cell Biol 2010; 11:208-19; PMID:20177396; http://dx.doi.org/ 10.1038/nrm2852
3. Leon-Ortiz AM, Svendsen J, Boulton SJ. Metabolism of DNA secondary structures at the eukaryotic replication fork. DNA Repair (Amst) 2014; 19:152-62; PMID:24815912; http://dx.doi.org/10.1016/j.dnarep. 2014.03.016
4. Jossen R, Bermejo R. The DNA damage checkpoint response to replication stress: a game of forks. Front Genet 2013; 4:26; PMID:23493417; http://dx.doi. org/10.3389/fgene.2013.00026
5. Blow JJ, Ge XQ, Jackson DA. How dormant origins promote complete genome replication. Trends Biochem Sci 2011; 36:405-14; PMID:21641805; http:// dx.doi.org/10.1016/j.tibs.2011.05.002
6. Paeschke K, McDonald KR, Zakian VA. Telomeres: structures in need of unwinding. FEBS Lett 2010; 584:3760-72; PMID:20637196; http://dx.doi.org/ 10.1016/j.febslet.2010.07.007
7. Miyake Y, Nakamura M, Nabetani A, Shimamura S, Tamura M, Yonehara S, Saito M, Ishikawa F. RPA-like mammalian Ctc1-Stn1-Ten1 complex binds to single-stranded DNA and protects telomeres independently of the Pot1 pathway. Mol Cell 2009; 36:193-206; PMID:19854130; http://dx.doi. org/10.1016/j.molcel.2009.08.009
8. Surovtseva YV, Churikov D, Boltz KA, Song X, Lamb JC, Warrington R, Leehy K, Heacock M, Price CM, Shippen DE. Conserved telomere maintenancecomponent 1 interacts with STN1 and maintains chromosome ends in higher eukaryotes. Mol Cell 2009; 36:207-18; PMID:19854131; http://dx.doi.org/ 10.1016/j.molcel.2009.09.017
9. Gu P, Min JN, Wang Y, Huang C, Peng T, Chai W, Chang S. CTC1 deletion results in defective telomere replication, leading to catastrophic telomere loss and stem cell exhaustion. EMBO J 2012; 31:2309-21; PMID:22531781; http://dx.doi.org/10.1038/emboj. 2012.96
10. Huang C, Dai X, Chai W. Human Stn1 protects telomere integrity by promoting efficient lagging-strand synthesis at telomeres and mediating C-strand fill-in. Cell Res 2012; 22:1681-95; PMID:22964711; http:// dx.doi.org/10.1038/cr.2012.132
11. Stewart JA, Wang F, Chaiken MF, Kasbek C, Chastain PD 2nd, Wright WE, Price CM. Human CST promotes telomere duplex replication and general replication restart after fork stalling. EMBO J 2012; 31:3537-49; PMID:22863775; http://dx.doi.org/ 10.1038/emboj.2012.215
12. Wang F, Stewart JA, Kasbek C, Zhao Y, Wright WE, Price CM. Human CST has independent functions during telomere duplex replication and C-strand fill-in. Cell Rep 2012; 2:1096-103; PMID:23142664; http:// dx.doi.org/10.1016/j.celrep.2012.10.007
13. Kasbek C, Wang F, Price CM. Human TEN1 maintains telomere integrity and functions in genome-wide replication restart. J Biol Chem 2013; 288:30139-50; PMID:24025336; http://dx.doi.org/10.1074/jbc. M113.493478
14. Giraud-Panis MJ, Teixeira MT, Geli V, Gilson E. CST meets shelterin to keep telomeres in check. Mol Cell 2010; 39:665-76; PMID:20832719; http://dx.doi.org/ 10.1016/j.molcel.2010.08.024
15. Price CM, Boltz KA, Chaiken MF, Stewart JA, Beilstein MA, Shippen DE. Evolution of CST function in telomere maintenance. Cell Cycle 2010; 9:3157-65; PMID:20697207; http://dx.doi.org/10.4161/ cc.9.16.12547
16. Chen LY, Redon S, Lingner J. The human CST complex is a terminator of telomerase activity. Nature 2012; 488:540-4; PMID:22763445; http://dx.doi.org/ 10.1038/nature11269
17. Mitton-Fry RM, Anderson EM, Theobald DL, Glustrom LW, Wuttke DS. Structural basis for telomeric single-stranded DNA recognition by yeast Cdc13. J Mol Biol 2004; 338:241-55; PMID:15066429; http:// dx.doi.org/10.1016/j.jmb.2004.01.063
18. Taggart AK, Teng SC, Zakian VA. Est1p as a cell cycleregulated activator of telomere-bound telomerase. Science 2002; 297:1023-6; PMID:12169735; http://dx. doi.org/10.1126/science.1074968
19. Gelinas AD, Paschini M, Reyes FE, Heroux A, Batey RT, Lundblad V, Wuttke DS. Telomere capping proteins are structurally related to RPA with an additional telomere-specific domain. Proc Natl Acad Sci U S A 2009; 106:19298-303; PMID:19884503; http://dx. doi.org/10.1073/pnas.0909203106
20. Bryan C, Rice C, Harkisheimer M, Schultz DC, Skordalakes E. Structure of the human telomeric Stn1-Ten1 capping complex. PLoS One 2013; 8:e66756; PMID:23826127; http://dx.doi.org/10.1371/journal. pone.0066756
21. Liu CC, Gopalakrishnan V, Poon LF, Yan T, Li S. Cdk1 regulates the temporal recruitment of telomerase and cdc13-stn1-ten1 complex for telomere replication. Mol Cell Biol 2014; 34:57-70; PMID:24164896; http://dx.doi.org/10.1128/MCB.01235-13
22. Li S, Makovets S, Matsuguchi T, Blethrow JD, Shokat KM, Blackburn EH. Cdk1-dependent phosphorylation of Cdc13 coordinates telomere elongation during cell-cycle progression. Cell 2009; 136:50-61; PMID:19135888; http://dx.doi.org/10.1016/j.cell.2008.11.027
23. Puglisi A, Bianchi A, Lemmens L, Damay P, Shore D. Distinct roles for yeast Stn1 in telomere capping and telomerase inhibition. EMBO J 2008; 27:2328-39; PMID:19172739; http://dx.doi.org/10.1038/ emboj.2008.158
24. Qi H, Zakian VA. The Saccharomyces telomere-binding protein Cdc13p interacts with both the catalytic subunit of DNA polymerase alpha and the telomeraseassociated est1 protein. Genes Dev 2000; 14:1777-88; PMID:10898792
25. Bianchi A, Shore D. How telomerase reaches its end: mechanism of telomerase regulation by the telomeric complex. Mol Cell 2008; 31:153-65; PMID: 18657499; http://dx.doi.org/10.1016/j.molcel.2008. 06.013
26. Goulian M, Heard CJ, Grimm SL. Purification and properties of an accessory protein for DNA polymerase alpha/primase. J Biol Chem 1990; 265:13221-30; PMID:2165497
27. Casteel DE, Zhuang S, Zeng Y, Perrino FW, Boss GR, Goulian M, Pilz RB. A DNA polymerase-{alpha}{middle dot}primase cofactor with homology to replication protein A-32 regulates DNA replication in mammalian cells. J Biol Chem 2009; 284:5807-18; PMID:19119139; http:// dx.doi.org/10.1074/jbc.M807593200
28. Armanios M. An emerging role for the conserved telomere component 1 (CTC1) in human genetic disease. Pediatr Blood Cancer 2012; 59:209-10; PMID: 22556055; http://dx.doi.org/10.1002/pbc.24200
29. Walne AJ, Bhagat T, Kirwan M, Gitiaux C, Desguerre I, Leonard N, Nogales E, Vulliamy T, Dokal IS. Mutations in the telomere capping complex in bone marrow failure and related syndromes. Haematologica 2013; 98:334-8; PMID:22899577; http://dx.doi.org/ 10.3324/haematol.2012.071068
30. Angstadt AY, Thayanithy V, Subramanian S, Modiano JF, Breen M. A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations. Cancer Genet 2012; 205:572-87; PMID:23137772; http://dx.doi.org/10.1016/j. cancergen.2012.09.005
31. Desmedt C, Piette F, Loi S, Wang Y, Lallemand F, Haibe-Kains B, Viale G, Delorenzi M, Zhang Y, d'Assignies MS, et al. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res 2007; 13:3207-14; PMID:17545524; http://dx.doi.org/ 10.1158/1078-0432.CCR-06-2765
32. Kao KJ, Chang KM, Hsu HC, Huang AT. Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization. BMC Cancer 2011; 11:143; PMID: 21501481; http://dx.doi.org/10.1186/1471-2407-11-143
33. Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res 2009; 11:R7; PMID:19187537; http://dx.doi. org/10.1186/bcr2222
34. www.Oncomine.Com. Bittner Sarcoma Dataset Summary. http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi? acc+GSE2109
35. Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, et al. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 2007; 7:55; PMID:17389037; http://dx.doi. org/10.1186/1471-2407-7-55
36. Calderon-Montano JM, Burgos-Moron E, Orta ML, Lopez-Lazaro M. Effect of DNA repair deficiencies on the cytotoxicity of drugs used in cancer therapy -a review. Curr Med Chem 2014; 21:3419-54; PMID:24934343
37. Chee CE, Meropol NJ. Current status of gene expression profiling to assist decision making in stage II colon xancer. Oncologist 2014; 19:704-11; PMID:24869929; http://dx. doi.org/10.1634/theoncologist.2013-0471
38. Abbotts R, Thompson N, Madhusudan S. DNA repair in cancer: emerging targets for personalized therapy. Cancer Manag Res 2014; 6:77-92; PMID:24600246
39. Klein HL. The consequences of Rad51 overexpression for normal and tumor cells. DNA Repair (Amst) 2008; 7:686-93; PMID:18243065; http://dx.doi.org/ 10.1016/j.dnarep.2007.12.008
40. Martinez-Marignac VL, Rodrigue A, Davidson D, Couillard M, Al-Moustafa AE, Abramovitz M, Foulkes WD, Masson JY, Aloyz R. The effect of a DNA repair gene on cellular invasiveness: XRCC3 over-expression in breast cancer cells. PLoS One 2011; 6:e16394; PMID:21283680; http://dx.doi.org/10.1371/journal. pone.0016394
41. Nakanoko T, Saeki H, Morita M, Nakashima Y, Ando K, Oki E, Ohga T, Kakeji Y, Toh Y, Maehara Y. Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus. Ann Surg Oncol 2014; 21:597-604; PMID:24065387; http://dx.doi. org/10.1245/s10434-013-3220-2
42. Jalal S, Earley JN, Turchi JJ. DNA repair: from genome maintenance to biomarker and therapeutic target. Clin Cancer Res 2011; 17:6973-84; PMID:21908578; http://dx.doi.org/10.1158/1078-0432.CCR-11-0761
43. Gu P, Chang S. Functional characterization of human CTC1 mutations reveals novel mechanisms responsible for the pathogenesis of the telomere disease Coats plus. Aging Cell 2013; 12:1100-9; PMID:23869908; http:// dx.doi.org/10.1111/acel.12139
44. Naim V, Rosselli F. The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nat Cell Biol 2009; 11:761-8; PMID:19465921; http://dx.doi.org/ 10.1038/ncb1883
45. Ying S, Minocherhomji S, Chan KL, Palmai-Pallag T, Chu WK, Wass T, Mankouri HW, Liu Y, Hickson ID. MUS81 promotes common fragile site expression. Nat Cell Biol; 15:1001-7; PMID:23811685; http://dx.doi. org/10.1038/ncb2773
46. Germann SM, Schramke V, Pedersen RT, Gallina I, Eckert-Boulet N, Oestergaard VH, Lisby M. TopBP1/ Dpb11 binds DNA anaphase bridges to prevent genome instability. J Cell Biol 2014; 204:45-59; PMID:24379413; http://dx.doi.org/10.1083/ jcb.201305157
47. Sfeir A, Kosiyatrakul ST, Hockemeyer D, MacRae SL, Karlseder J, Schildkraut CL, de Lange T. Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 2009; 138:90-103; PMID:19596237; http://dx.doi.org/10.1016/j. cell.2009.06.021
48. Karnani N, Dutta A. The effect of the intra-S-phase checkpoint on origins of replication in human cells. Genes Dev 2011; 25:621-33; PMID:21406556; http:// dx.doi.org/10.1101/gad.2029711
49. Ge XQ, Blow JJ. Chk1 inhibits replication factory activation but allows dormant origin firing in existing factories. J Cell Biol 2010; 191:1285-97; PMID: 21173116; http://dx.doi.org/10.1083/jcb.201007074
50. Petermann E, Orta ML, Issaeva N, Schultz N, Helleday T. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol Cell 2010; 37:492-502; PMID:20188668; http://dx. doi.org/10.1016/j.molcel.2010.01.021
51. Toledo LI, Altmeyer M, Rask MB, Lukas C, Larsen DH, Povlsen LK, Bekker-Jensen S, Mailand N, Bartek J, Lukas J. ATR prohibits replication catastrophe by preventing global exhaustion of RPA. Cell 2013; 155:1088-103; PMID:24267891; http://dx.doi.org/ 10.1016/j.cell.2013.10.043
52. Davies SL, North PS, Hickson ID. Role for BLM in replication-fork restart and suppression of origin firing after replicative stress. Nat Struc Mol Biol 2007; 14:677-9; PMID:17603497; http://dx.doi.org/ 10.1038/nsmb1267
53. Vannier JB, Sandhu S, Petalcorin MI, Wu X, Nabi Z, Ding H, Boulton SJ. RTEL1 is a replisome-associated helicase that promotes telomere and genome-wide replication. Science 2013; 342:239-42; PMID:24115439; http://dx.doi.org/10.1126/science.1241779
54. Wyatt MD, Pittman DL. Methylating agents and DNA repair responses: Methylated bases and sources of strand breaks. Chem Res Toxicol 2006; 19:1580-94; PMID: 17173371; http://dx.doi.org/10.1021/tx060164e
55. Groth P, Auslander S, Majumder MM, Schultz N, Johansson F, Petermann E, Helleday T. Methylated DNA causes a physical block to replication forks independently of damage signalling, O(6)-methylguanine or DNA single-strand breaks and results in DNA damage. J Mol Biol 2010; 402:70-82; PMID:20643142; http://dx.doi.org/10.1016/j.jmb.2010.07.010
56. Hsiang YH, Lihou MG, Liu LF. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res 1989; 49:5077-82; PMID: 2548710
57. Regairaz M, Zhang YW, Fu H, Agama KK, Tata N, Agrawal S, Aladjem MI, Pommier Y. Mus81-mediated DNA cleavage resolves replication forks stalled by topoisomerase I-DNA complexes. J Cell Biol 2011; 195:739-49; PMID:22123861; http://dx.doi.org/ 10.1083/jcb.201104003
58. Clauson C, Scharer OD, Niedernhofer L. Advances in understanding the complex mechanisms of DNA interstrand cross-link repair. Cold Spring Harb Perspect Biol 2013; 5:a012732; PMID:24086043; http://dx. doi.org/10.1101/cshperspect.a012732
59. Huang M, Kim JM, Shiotani B, Yang K, Zou L, D'Andrea AD. The FANCM/FAAP24 complex is required for the DNA interstrand crosslink-induced checkpoint response. Mol Cell 2010; 39:259-68; PMID:20670894; http://dx.doi.org/10.1016/j. molcel.2010.07.005
60. Tomida J, Itaya A, Shigechi T, Unno J, Uchida E, Ikura M, Masuda Y, Matsuda S, Adachi J, Kobayashi M, et al. A novel interplay between the Fanconi anemia core complex and ATR-ATRIP kinase during DNA cross-link repair. Nucleic Acids Res 2013; 41:6930-41; PMID:23723247; http://dx.doi.org/10.1093/nar/ gkt467
61. Nam EA, Cortez D. ATR signalling: more than meeting at the fork. Biochem J 2011; 436:527-36; PMID:21615334; http://dx.doi.org/10.1042/ BJ20102162
62. Sheu YJ, Kinney JB, Lengronne A, Pasero P, Stillman B. Domain within the helicase subunit Mcm4 integrates multiple kinase signals to control DNA replication initiation and fork progression. Proc Natl Acad Sci U S A 2014; 111:E1899-908; PMID:24740181; http://dx. doi.org/10.1073/pnas.1404063111
63. Liu P, Barkley LR, Day T, Bi X, Slater DM, Alexandrow MG, Nasheuer HP, Vaziri C. The Chk1-mediated S-phase checkpoint targets initiation factor Cdc45 via a Cdc25A/Cdk2-independent mechanism. J Biol Chem 2006; 281:30631-44; PMID:16912045; http://dx.doi. org/10.1074/jbc.M602982200
64. Chen LY, Majerska J, Lingner J. Molecular basis of telomere syndrome caused by CTC1 mutations. Genes Dev 2013; 27:2099-108; PMID:24115768; http://dx. doi.org/10.1101/gad.222893.113
65. Luo YM, Xia NX, Yang L, Li Z, Yang H, Yu HJ, Liu Y, Lei H, Zhou FX, Xie CH, et al. CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis. Int J Mol Med 2014; 33:1484-90; PMID:24718655
66. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63; PMID:6606682; http://dx.doi.org/10.1016/0022-1759(83)90303-4